Update: 2017-10-17  Visitor: 0000208003
:::
Search
:::

Development Center for Biotechnology (DCB)

Development Center for Biotechnology (DCB)

 

The Development Center for Biotechnology (DCB)’s objective is to advance Taiwan’s biopharmaceutical industry. DCB works with government, industry and academia to develop the nation’s scientific infrastructure, key technologies, and talent. DCB conducts R&D in pharmaceuticals, botanicals, biologics, animal pharmacology as well as innovative and explorative preclinical-stage research. One of DCB’s key roles is to set priorities for attaining investigational new drug approvals by domestic and foreign regulatory agencies. New drug development is focused on cancer, diabetes, infectious, inflammatory and cardiovascular diseases.

Last update: 2017-08-25

Go Back Top